Anna Mamo, MS, MBA
Director, Translational Sciences
Anna Mamo has a broad background in the biological sciences and experience in business case development to support the UPMC Enterprises Translational Sciences team. Ms. Mamo’s early career focused on research, with time spent in academic labs focusing in genetics and immunology. She has previous experience with a Pittsburgh-based start-up company, Carmell Therapeutics, which developed regenerative bone and tendon therapies. After developing an interest in the business side of science, she went back to school for her MBA at the Katz Graduate School of Business. After graduating, Ms. Mamo worked on commercializing health care-related technologies that spun out of Pittsburgh universities. She spent time with the Coulter Foundation, Idea Foundry, and Highmark Health, in their innovation and strategic partnership departments. After helping to launch an enterprise-wide technology commercialization process (VITAL) at Highmark, she left for UPMC Health Plan, where she led a team developing business cases for consumer-facing digital technologies. Ms. Mamo graduated from Grove City College with a Bachelor’s degree in Biology and French and followed her undergraduate education with a Master’s degree in Microbiology and Infectious Disease from the Pitt Graduate School of Public Health.
More Team Members
Philip Jones, PhD
Vice President, Science & Discovery, Translational Sciences
Matthias Kleinz, DVM, PhD
Leadership Translational Sciences
Executive Vice President, Translational Sciences